Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(17%)
Terminated
1(17%)

Phase Distribution

Ph phase_1
1
17%
Ph not_applicable
5
83%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Terminated(3)
Other(2)

Detailed Status

Withdrawn2
unknown2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (16.7%)
N/A5 (83.3%)

Trials by Status

terminated117%
withdrawn233%
recruiting117%
unknown233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
6